Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Welliver

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
The Journal of Infectious Diseases|December 1, 1977
Clinical trials with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza vaccines in Los Angeles childrenK M Boyer, J D Cherry, R C Welliver, et al.
Annals of Internal Medicine|June 1, 1979
Epidemic measles in young adults. Clinical, epidemiologic, and serologic studiesP J Krause, J D Cherry, J Deseda-Tous, et al.
Pediatric Research|September 1, 1979
Sales of nonprescription cold remedies: a unique method of influenza surveillanceR C Welliver, J D Cherry, K M Boyer, et al.
The New England Journal of Medicine|November 18, 1993
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study GroupJ R Groothuis, E A Simoes, M J Levin, et al.
The Journal of Infectious Diseases|December 1, 1977
IgM and IgG antibody responses after immunization of children with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza virus vaccinesK M Boyer, J D Cherry, R C Welliver, et al.
Pediatrics|March 1, 1997
Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study GroupW J Rodriguez, W C Gruber, R C Welliver, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1999
Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV diseaseH C Meissner, J R Groothuis, W J Rodriguez, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
The Journal of Infectious Diseases|December 1, 1977
Clinical trials with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza vaccines in Los Angeles childrenK M Boyer, J D Cherry, R C Welliver, et al.
Annals of Internal Medicine|June 1, 1979
Epidemic measles in young adults. Clinical, epidemiologic, and serologic studiesP J Krause, J D Cherry, J Deseda-Tous, et al.
Pediatric Research|September 1, 1979
Sales of nonprescription cold remedies: a unique method of influenza surveillanceR C Welliver, J D Cherry, K M Boyer, et al.
The New England Journal of Medicine|November 18, 1993
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study GroupJ R Groothuis, E A Simoes, M J Levin, et al.
The Journal of Infectious Diseases|December 1, 1977
IgM and IgG antibody responses after immunization of children with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza virus vaccinesK M Boyer, J D Cherry, R C Welliver, et al.
Pediatrics|March 1, 1997
Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study GroupW J Rodriguez, W C Gruber, R C Welliver, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1999
Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV diseaseH C Meissner, J R Groothuis, W J Rodriguez, et al.
Pageof 9